A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions

Status:
Completed

Trial end date:
2017-11-20

Target enrollment:

Participant gender:

This is a safety and efficacy study of LiRIS® in females with interstitial cystitis with Hunner's lesions.

Phase 2

Allergan

Lidocaine